Shed (formerly ShedRx) Review: More Ways to Take a GLP-1 Than Anyone — If the Medication Actually Arrives

What Is Shed (formerly ShedRx)?

First, a naming note, because it causes real confusion. This company launched as ShedRx and has rebranded to Shed — shedrx.com now redirects to tryshed.com. The legal entity and operations are the same, and older directories still list it under the old name. We have kept this review at its original URL for that reason.

Shed is a multi-category telehealth platform. Weight loss is its flagship line, but the same account also covers sexual health, longevity and vitality, and hair — a structure closer to Hims or Hers than to a single-purpose GLP-1 seller.

What makes it genuinely distinctive is format breadth. Most providers offer a weekly compounded injection and stop there. Shed lists compounded semaglutide and tirzepatide injections, GLP-1 liquid drops taken daily with no needle, sublingual GLP-1 lozenges, Foundayo (the orforglipron pill), and brand-name Wegovy and Zepbound pens. It also sells a low-dose 'Microdose GLP-1' weekly injection under its longevity line, and adjunct non-GLP-1 options including metformin/naltrexone/topiramate and naltrexone/bupropion capsules.

This review has been substantially revised. Our earlier assessment was based on Shed's published pricing page and rated the service highly on format range. Having since examined the independent complaint record, we have downgraded it sharply. The BBB lists Shed at 3401 N Thanksgiving Way, Lehi, UT, with a start date of 1 December 2022, no accreditation, and 250 complaints over three years with 93 closed in the last twelve months. The complaints are not about pricing or side effects — they are about paying and not receiving.

Medications Offered & Pricing

Shed advertises compounded semaglutide as low as $159/mo and compounded tirzepatide from $239/mo. Prices for the drops, lozenges, Foundayo, Wegovy, Zepbound and adjunct medications are not published as standalone figures — they are quoted after you select a product and plan, and the 'as low as' rates reflect longer prepaid plans rather than a single month. Independent coverage also reports dose-escalation pricing on some plans, where a patient starting around $199/mo sees the cost rise as their dose increases. Confirm both your starting price and your price at a maintenance dose before subscribing.

Brand-Name or Compounded?

Shed sells both compounded and brand-name products. The semaglutide and tirzepatide injections, drops and lozenges are compounded preparations. Wegovy, Zepbound and Foundayo are brand-name, FDA-approved products.

Being able to move between the two without changing providers is a real practical advantage. If you start on compounded tirzepatide and later gain insurance coverage for Zepbound — or simply decide you would rather be on an FDA-approved product — you can switch inside the same account.

Shed's disclosure is accurate: 'Compounded medications are not FDA-approved and are made by a licensed pharmacy based on a provider's prescription.' Compounded semaglutide and tirzepatide are not generic versions of Ozempic, Wegovy, Mounjaro or Zepbound, and have not been reviewed by the FDA for safety, efficacy or manufacturing quality.

Two items deserve extra scepticism. The GLP-1 drops and lozenges have no published evidence establishing that they deliver comparable drug exposure to an injection — semaglutide absorbs poorly by mouth, and the one FDA-approved oral version needs a specific absorption enhancer to work at all. The 'Microdose GLP-1' line is a commercial protocol, not an evidence-based regimen; there is no outcome data showing microdosed GLP-1 produces the metabolic benefits marketed.

The Consultation Process

Eligibility

• •Eligibility is determined by a licensed prescriber after online intake — Shed does not publish a public BMI cutoff.
• •The 120-day guarantee is tied to losing 5% of body weight, so its terms effectively set expectations for who the program suits. Read the qualifying conditions, which typically require documented adherence.
• •Adjunct non-GLP-1 options exist for patients who may not qualify for or tolerate a GLP-1.
• •State-by-state availability is not published — confirm before subscribing.
• •GLP-1 medicines are contraindicated in people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2, and must not be used in pregnancy or while trying to conceive. Clinician judgement is required with a history of pancreatitis, gallbladder disease, gastroparesis or diabetic retinopathy.
• •Common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation and reflux — usually worst after a dose increase.
• •A practical safety point specific to this provider: interrupted supply is a real risk here. If you are titrating and a shipment does not arrive, do not attempt to stretch or re-dose remaining medication to compensate — contact a clinician.

Provider Involvement, Labs & Pharmacy

Shipping & Support Services

This is the core problem with the service and the reason for the downgrade. Medication ships as part of a prescription subscription, but the BBB file is dominated by non-delivery. Complainants state: 'I have paid for 29 shipments of med. I have gotten 10'; 'charged $199.99 monthly without receiving any products' over a March-to-June 2026 period; and 'I spent $8841 for meds I didn't get', with only partial credit applied. Others describe long processing times and medication arriving sporadically. Several tie the deterioration to the switch to TryShed. Before subscribing, assume delivery is not guaranteed and never prepay a long plan.

• •Health coaching program
• •Member Portal for managing your subscription
• •Community and resources via the member area
• •Referral program and Help Center
• •Free Clear Protein + Hydration bonus with a new prescription subscription
• •Both compounded and brand-name medication in one account

Fees, Cancellation & Refunds

Insurance & HSA/FSA

Pros & Cons

Who Shed (formerly ShedRx) May Be Best For

• •Very few readers on the current record — the fulfilment failures outweigh the product range
• •Patients who genuinely cannot inject and have exhausted other options, paying month to month on a disputable card
• •Existing customers receiving reliable shipments who want to understand the wider complaint pattern

Limitations

• •The format range is real and the fulfilment record undoes it. Being the only provider offering drops, lozenges, a pill, compounded injections and brand-name pens in one account is a genuine advantage for people who will not inject. None of it matters if the medication does not arrive, and the BBB file is dominated by exactly that: 250 complaints in three years, with complainants describing receiving 10 of 29 paid shipments, months of $199.99 charges against no product, and $8,841 spent on medication never received.
• •Non-delivery is a clinical problem, not just a commercial one. GLP-1 therapy involves titration, and an interrupted supply mid-escalation means restarting tolerance or going without. A provider whose most common failure mode is not shipping is a poor choice for a medication where continuity matters.
• •The cancellation reports compound the risk. A cancellation link described as unclickable, no live phone answer, and multi-day chat responses means the practical route out of a subscription may be your card issuer rather than the company. If you subscribe, use a card you can dispute and keep every record.
• •Pricing opacity makes the service hard to evaluate even before delivery. Only semaglutide and tirzepatide have public rates; the drops, lozenges, Foundayo, Wegovy and Zepbound are all quoted after selection, and dose-escalation pricing is reported on some plans. At $159/mo starting, Shed is already well above CallonDoc at $89 and CoreAge Rx at $99.
• •We have downgraded this review from 4.4 to 2.2. The earlier rating was based on Shed's published product range and pricing page without examining the independent complaint record — that was too narrow a basis, and the product breadth that impressed us does not survive contact with the delivery data.
• •In fairness, the company has been trading since December 2022, does carry genuine brand-name options, and its compounded-medication disclosure is accurate and unhedged. Plenty of customers evidently receive their medication. But the volume and consistency of non-delivery complaints is too high to recommend around.

Alternatives to Consider

Frequently Asked Questions

Our Verdict

On product design Shed is genuinely the most interesting provider we have reviewed. Nobody else offers weekly compounded injections, needle-free daily drops, sublingual lozenges, an oral pill and brand-name Wegovy and Zepbound inside one account, with adjunct non-GLP-1 options for patients who cannot use a GLP-1 at all. For someone who will not inject, that range is close to unmatched, and being able to move between compounded and brand-name without changing provider is a real advantage.

The delivery record makes it hard to recommend any of it. The Better Business Bureau lists 250 complaints against the company over three years, and they are overwhelmingly about paying and not receiving — one customer describing 10 shipments out of 29 paid for, another months of $199.99 charges against no product, another $8,841 spent on medication that never came. Add a cancellation link complainants say does not work, no live phone answer and multi-day chat replies, and the practical risk is not that the medication disappoints but that it never shows up while the billing continues.

That is a particular problem for GLP-1 therapy, where titration means an interrupted supply is not a minor inconvenience. And at $159/mo starting, Shed is not cheap enough to justify the gamble — CallonDoc is $89/mo with an A+ BBB rating and CoreAge Rx is $99/mo.

We rate Shed 2.2 out of 5, downgraded from our earlier 4.4. That earlier rating was based on the company's own product range and pricing page without examining the independent complaint record, and it was wrong. The catalogue is excellent; the fulfilment is not.

If the needle-free formats are genuinely decisive for you, pay month to month on a card you can dispute, never prepay a long plan, and keep records of every charge and shipment. Otherwise, choose a provider with a delivery record.

This review is informational only and is not medical advice. Compounded GLP-1s are not FDA-approved and have not been evaluated for safety, efficacy or quality. Speak to a licensed clinician about whether treatment is appropriate for you before starting, changing or stopping any medication.